Breanna Taylor, PharmD, BCOP

Articles by Breanna Taylor, PharmD, BCOP

Leukemia cell presence in blood smear observed under microscope in acute myeloid leukemia | Image Credit: © Prasanth - stock.adobe.com

Integrating Novel Therapies for NPM1-Mutated AML: The Expanding Role of the Oncology Pharmacist in Precision Treatment and Supportive Care

August 5th 2026

Revumenib and ziftomenib in NPM1-mutated AML: practical guidance on differentiation syndrome, QTc monitoring, and drug interactions.

Updates in the Management of Transplant-Ineligible Patients With Multiple Myeloma

ByBreanna Taylor, PharmD, BCOP

May 1st 2025

Explore the latest advancements in treating transplant-ineligible multiple myeloma, highlighting new therapies and clinical trial outcomes for improved patient care.

A Review of Axatilimab in Steroid Refractory Chronic Graft versus Host Disease

ByBreanna Taylor, PharmD, BCOP

January 27th 2025

Axatilimab-csfr is a colony-stimulating factor-1 receptor (CSFR1) blocking monoclonal antibody indicated for cGVHD after 2 or more lines of prior therapy in adults and pediatric patients that weigh at least 40 kg.